About GENimmune
GENimmune is a biopharmaceutical company developing immune therapeutics to cure and prevent human disease by optimizing the immune response. The new company intends to become a key player in the treatment of major, intractable diseases by the creation of a broad and effective pipeline of modern immune therapeutics and vaccines. It will do so by synergizing its technical and clinical expertise for in-house product development, co-development projects, and biomanufacturing partnerships.
GENimmune is currently developing novel therapeutic vaccines and monoclonal antibodies against chronic diseases caused by the hepatitis B and hepatitis C viruses, as well as against human papillomavirus, the cause of cervical cancer.
GENimmune is a wholly owned subsidiary of Innogenetics NV.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of GENimmune
News about GENimmune
Here you will find GENimmune NV
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
